PB leukemia cells (GFP+B220+) for the recipient mice was monitored on days 15, 18, 22, 25 and 29 post BMT, the percentage and total number of leukemia cells was significantly lower in BCR/ABL1-Rora group recipients (Figure 7B and C). This evidence concerns the gene BCR and leukemia.